Target type: biologicalprocess
Any process that increases the frequency, rate or extent of the multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage. [GO_REF:0000058, GOC:TermGenie, PMID:23212449]
Positive regulation of chondrocyte proliferation is a complex and multifaceted process that plays a crucial role in the development, growth, and repair of cartilage. This intricate biological process involves a coordinated interplay of signaling pathways, transcription factors, and growth factors, orchestrating the precise balance between chondrocyte proliferation and differentiation. The intricate choreography of this process ensures the formation of a robust and resilient cartilage matrix, which provides structural support and cushioning to joints.
**Key Signaling Pathways**
* **Fibroblast Growth Factor (FGF) signaling pathway:** FGFs, such as FGF-2, FGF-18, and FGF-9, are potent stimulators of chondrocyte proliferation. They bind to FGF receptors (FGFRs) on the chondrocyte cell surface, activating downstream signaling cascades involving the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) pathways. These pathways ultimately lead to the activation of transcription factors, such as c-Fos and c-Jun, which promote cell cycle progression and proliferation.
* **Insulin-like Growth Factor (IGF) signaling pathway:** IGFs, like IGF-1 and IGF-2, are also potent growth factors that stimulate chondrocyte proliferation. They bind to IGF receptors (IGFRs) on the chondrocyte cell surface, initiating signaling cascades that activate the MAPK and PI3K pathways. This ultimately leads to the activation of transcription factors, such as c-Myc and E2F, which promote cell cycle progression and proliferation.
* **Platelet-Derived Growth Factor (PDGF) signaling pathway:** PDGFs, such as PDGF-A and PDGF-B, play a significant role in chondrocyte proliferation, particularly during cartilage repair. They bind to PDGF receptors (PDGFRs) on the chondrocyte cell surface, activating downstream signaling pathways that activate the MAPK and PI3K pathways. These pathways ultimately lead to the activation of transcription factors, such as c-Jun and STATs, which promote cell cycle progression and proliferation.
* **Wnt signaling pathway:** Wnt signaling plays a crucial role in chondrocyte proliferation and differentiation. Wnt proteins activate the canonical Wnt pathway, which involves the stabilization of β-catenin, a key transcription factor that promotes chondrocyte proliferation and differentiation.
**Transcription Factors**
* **Sox9:** A master regulator of chondrogenesis, Sox9 plays a pivotal role in chondrocyte proliferation and differentiation. It binds to specific DNA sequences, activating the expression of genes involved in chondrocyte function, including collagen type II, aggrecan, and other extracellular matrix components.
* **Runx2:** A transcription factor that plays a crucial role in chondrocyte proliferation and differentiation. Runx2 promotes the expression of genes involved in chondrocyte differentiation and matrix formation, leading to the formation of mature chondrocytes.
**Growth Factors**
* **Growth Hormone (GH):** GH stimulates chondrocyte proliferation indirectly by inducing the production of IGF-1 in the liver, which then acts on chondrocytes to promote proliferation.
* **Insulin:** Insulin can also stimulate chondrocyte proliferation, particularly in the presence of IGF-1.
**Regulation of Chondrocyte Proliferation**
* **Mechanical stimulation:** Mechanical stress and loading can influence chondrocyte proliferation and differentiation. Compression forces can activate signaling pathways that promote proliferation and matrix synthesis, while tensile forces can promote differentiation.
* **Oxygen tension:** Chondrocytes are sensitive to changes in oxygen tension. Hypoxia, or low oxygen levels, can promote chondrocyte proliferation, while hyperoxia, or high oxygen levels, can inhibit proliferation and induce apoptosis.
* **Hormones:** Hormones such as estrogen, testosterone, and thyroid hormone can influence chondrocyte proliferation and differentiation. For example, estrogen promotes chondrocyte proliferation and inhibits differentiation, while testosterone promotes differentiation.
* **Age:** Chondrocyte proliferation decreases with age, leading to a decline in cartilage repair capacity.
**Dysregulation of Chondrocyte Proliferation**
* **Arthritis:** In osteoarthritis, chondrocytes undergo accelerated apoptosis and reduced proliferation, leading to cartilage degradation and joint damage.
* **Chondrodysplasia:** Genetic disorders that affect chondrocyte proliferation can lead to skeletal abnormalities, such as dwarfism.
**Therapeutic Implications**
Understanding the mechanisms that regulate chondrocyte proliferation is crucial for developing novel therapeutic strategies for cartilage repair and regeneration.
* **Growth factor therapy:** Growth factors, such as FGF-2, IGF-1, and PDGF, are being investigated as potential therapeutic agents for cartilage repair.
* **Gene therapy:** Gene therapy approaches are being explored to deliver genes that encode growth factors or other proteins that stimulate chondrocyte proliferation and matrix synthesis.
* **Cell therapy:** Chondrocytes can be cultured in vitro and implanted to regenerate damaged cartilage.
In conclusion, positive regulation of chondrocyte proliferation is an essential biological process that ensures the proper formation, growth, and repair of cartilage. It involves a complex interplay of signaling pathways, transcription factors, and growth factors, regulated by various factors including mechanical stimulation, oxygen tension, hormones, and age. Dysregulation of this process can lead to cartilage degeneration and joint diseases. Understanding the intricate mechanisms underlying chondrocyte proliferation is crucial for developing effective therapeutic strategies for cartilage repair and regeneration.'"
Protein | Definition | Taxonomy |
---|---|---|
NAD-dependent protein deacetylase sirtuin-6 | An NAD-dependent protein deacylase sirtuin-6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8N6T7] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
niacinamide | nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group. | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor |
pyrazinamide | pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis. | monocarboxylic acid amide; N-acylammonia; pyrazines | antitubercular agent; prodrug |
pyrazinoic acid | pyrazine-2-carboxylic acid : The parent compound of the class of pyrazinecarboxylic acids, that is pyrazine bearing a single carboxy substituent. The active metabolite of the antitubercular drug pyrazinamide. pyrazinoic acid: active metabolite of pyrazinamide; structure | pyrazinecarboxylic acid | antitubercular agent; drug metabolite |
1-(4-nitrophenyl)piperazine | 1-(4-nitrophenyl)piperazine: structure in first source | ||
rubimaillin | rubimaillin : A benzochromene that is 2H-benzo[h]chromene which is substituted by two methyl groups at position 2, a methoxycarbonyl group at position 5, and a hydroxy group at position 6. Found in the Chinese medical plant Rubia cordifola, It has an anti-cancer effect by inhibition of TNF-alpha-induced NF-kappaB activation. It is also a dual inhibitor of acyl-CoA:cholesterol acyltransferase 1 and 2 (ACAT1 and ACAT2), but is more selective for the ACAT2 isozyme. rubimaillin: structure given in first source | benzochromene; methyl ester; phenols | acyl-CoA:cholesterol acyltransferase 2 inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; neuroprotective agent; NF-kappaB inhibitor; plant metabolite |
5-chloropyrazinamide | |||
trichostatin a | trichostatin A: chelates zinc ion in the active site of histone deacetylases, resulting in preventing histone unpacking so DNA is less available for transcription; do not confuse with TRICHOSANTHIN which is a protein; found in STREPTOMYCES | antibiotic antifungal agent; hydroxamic acid; trichostatin | bacterial metabolite; EC 3.5.1.98 (histone deacetylase) inhibitor; geroprotector |
(3R,5S)-fluvastatin | (3R,5S)-fluvastatin : A (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid diastereoisomer in which the stereocentres beta- and delta- to the carboxy group have R and S configuration, respectively. The drug fluvastatin is an equimolar mixture of this compound and its enantiomer. | (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; statin (synthetic) | |
ly2784544 | pyridazines |